P3 Health Partners Inc (NASDAQ: PIII) shares are trading higher by around 10% after the company reaffirmed guidance for 2023 and announced the 2024 outlook.
FY24 Outlook: PIII expects revenue of $1.45 billion to $1.55 billion (vs. consensus $1.41 billion) and Adjusted EBITDA of $20 million to $40 million.
The company anticipated Medicare Advantage Members of 125,000- 135,000, Medical Margin of $230 million-$250 million and Medical Margin PMPM of $165-$175.
FY23 Outlook: The company reiterated guidance for revenue of $1.2 billion-$1.25 billion (vs. consensus $1.22 billion) and Medicare Advantage Members of ...